CTOs on the Move

Polyfoam Corp

www.polyfoamcorp.com

 
Polyfoam Corp is a Northbridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Blink Health

The cure for high drug prices. Blink is the first company to allow patients to purchase their medications online and pick them up at their local pharmacy. Blink is using technology to get you affordable prices on your prescription medications. We are the alternative to rising copays and high cash prices. Use Blink at over 57,000 U.S. pharmacies, including major chains and independent pharmacies. Blink provides significant savings, even if you have insurance. It`s available to anyone as an alternate to your copay or cash price. Blink is free to use: there are no premiums or membership fees.

RAAS BLOOD PRODUCTS CO.

RAAS BLOOD PRODUCTS CO., LTD. is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Galen Healthcare Solutions

Galen Healthcare Solutions is a Burlington, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St Agnes Home

St Agnes Home is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.